Patents by Inventor David Fairman

David Fairman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-B7-H1 antibodies for treating tumors
    Patent number: 11827706
    Abstract: Provided herein are methods of treating B7-H1-expressing tumors comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: November 28, 2023
    Inventors: Rajesh Narwal, David Fairman, Paul Robbins, Meina Liang, Amy Schneider, Carlos Chavez, Carina Herl, Min Pak, Hong Lu, Marlon Rebelatto, Keith Steele, Anmarie Boutrin, Li Shi, Shengyan Hong, Brandon Higgs, Lorin Roskos
  • ANTI-PAR2 ANTIBODIES AND USES THEREOF
    Publication number: 20230242639
    Abstract: The present disclosure provides antibodies and antigen-binding fragments capable of binding PAR2. In some embodiments, the anti-PAR2 antibodies or antigen-binding fragments thereof bind PAR2 in a pH-dependent manner. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.
    Type: Application
    Filed: February 7, 2023
    Publication date: August 3, 2023
    Inventors: Claire DOBSON, Richard WILLIAMS, Ian GURRELL, Sadhana PODICHETTY, David FAIRMAN, Peter THORNTON, Philip NEWTON
  • Nucleic acids encoding anti-PAR2 antibodies and uses thereof
    Patent number: 11591389
    Abstract: The present disclosure provides antibodies and antigen-binding fragments capable of binding PAR2. In some embodiments, the anti-PAR2 antibodies or antigen-binding fragments thereof bind PAR2 in a pH-dependent manner. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.
    Type: Grant
    Filed: September 29, 2020
    Date of Patent: February 28, 2023
    Assignee: MEDIMMUNE LIMITED
    Inventors: Claire Dobson, Richard Williams, Ian Gurrell, Sadhana Podichetty, David Fairman, Peter Thornton, Philip Newton
  • GLUCAGON/GLP-1 AGONISTS FOR THE TREATMENT OF OBESITY
    Publication number: 20220098265
    Abstract: This disclosure provides GLP-1/glue agon agonist peptides for the treatment of metabolic diseases, e.g., obesity.
    Type: Application
    Filed: December 14, 2021
    Publication date: March 31, 2022
    Inventors: BALAJI AGORAM, Madeleine Antonsson, MARIA A. BEDNAREK, Nicole Burmeister, Lambertus Benthem, DAVID FAIRMAN, MARIA FRITSCH-FREDIN, Ronald JACKSON, Rasmus Jansson Lofmark, Jacqueline Metcalfe
  • Glucagon/GLP-1 agonists for the treatment of obesity
    Patent number: 11230584
    Abstract: This disclosure provides GLP-1/glue agon agonist peptides for the treatment of metabolic diseases, e.g., obesity.
    Type: Grant
    Filed: December 20, 2019
    Date of Patent: January 25, 2022
    Assignee: MEDIMMUNE LIMITED
    Inventors: Balaji Agoram, Madeleine Antonsson, Maria A. Bednarek, Nicole Burmeister, Lambertus Benthem, David Fairman, Maria Fritsch-Fredin, Ronald Jackson, Rasmus Jansson Lofmark, Jacqueline Metcalfe
  • ANTI-B7-H1 ANTIBODIES FOR TREATING TUMORS
    Publication number: 20210171639
    Abstract: Provided herein are methods of treating B7-H1-expressing tumors comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof.
    Type: Application
    Filed: October 16, 2020
    Publication date: June 10, 2021
    Inventors: RAJESH NARWAL, DAVID FAIRMAN, PAUL ROBBINS, MEINA LIANG, AMY SCHNEIDER, CARLOS CHAVEZ, CARINA HERL, MIN PAK, HONG LU, MARLON REBELATTO, KEITH STEELE, ANMARIE BOUTRIN, LI SHI, SHENGYAN HONG, BRANDON HIGGS, LORIN ROSKOS
  • ANTI-PAR2 ANTIBODIES AND USES THEREOF
    Publication number: 20210061905
    Abstract: The present disclosure provides antibodies and antigen-binding fragments capable of binding PAR2. In some embodiments, the anti-PAR2 antibodies or antigen-binding fragments thereof bind PAR2 in a pH-dependent manner. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.
    Type: Application
    Filed: September 29, 2020
    Publication date: March 4, 2021
    Inventors: Claire Dobson, Richard Williams, Ian Gurrell, Sadhana Podichetty, David Fairman, Peter Thornton, Philip Newton
  • Anti-PAR2 antibodies and uses thereof
    Patent number: 10836822
    Abstract: The present disclosure provides antibodies and antigen-binding fragments capable of binding PAR2. In some embodiments, the anti-PAR2 antibodies or antigen-binding fragments thereof bind PAR2 in a pH-dependent manner. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: November 17, 2020
    Assignee: MedImmune Limited
    Inventors: Claire Dobson, Richard Williams, Ian Gurrell, Sadhana Podichetty, David Fairman, Peter Thornton, Philip Newton
  • Anti-B7-H1 antibodies for treating tumors
    Patent number: 10829557
    Abstract: Provided herein are methods of treating B7-H1-expressing tumors comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof.
    Type: Grant
    Filed: May 21, 2019
    Date of Patent: November 10, 2020
    Assignee: MEDIMMUNE LIMITED
    Inventors: Rajesh Narwal, David Fairman, Paul Robbins, Meina Liang, Amy Schneider, Carlos Chavez, Carina Herl, Min Pak, Hong Lu, Marlon Rebelatto, Keith Steele, Anmarie Boutrin, Li Shi, Shengyan Hong, Brandon Higgs, Lorin Roskos
  • GLUCAGON/GLP-1 AGONISTS FOR THE TREATMENT OF OBESITY
    Publication number: 20200115431
    Abstract: This disclosure provides GLP-1/glue agon agonist peptides for the treatment of metabolic diseases, e.g., obesity.
    Type: Application
    Filed: December 20, 2019
    Publication date: April 16, 2020
    Inventors: Balaji AGORAM, Madeleine Antonsson, Maria A. Bednarek, Nicole Burmeister, Lambertus Benthem, David FAIRMAN, Maria FRITSCH-FREDIN, Ronald Jackson, Rasmus Jansson Lofmark, Jacqueline Metcalfe
  • Glucagon/GLP-1 agonists for the treatment of obesity
    Patent number: 10556939
    Abstract: This disclosure provides GLP-1/glue agon agonist peptides for the treatment of metabolic diseases, e.g., obesity.
    Type: Grant
    Filed: August 10, 2017
    Date of Patent: February 11, 2020
    Assignee: MEDIMMUNE LIMITED
    Inventors: Balaji Agoram, Madeleine Antonsson, Maria A. Bednarek, Nicole Burmeister, Lambertus Benthem, David Fairman, Maria Fritsch-Fredin, Ronald Jackson, Rasmus Jansson Lofmark, Jacqueline Metcalfe
  • ANTI-B7-H1 ANTIBODIES FOR TREATING TUMORS
    Publication number: 20190338033
    Abstract: Provided herein are methods of treating B7-H1-expressing tumors comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof.
    Type: Application
    Filed: May 21, 2019
    Publication date: November 7, 2019
    Inventors: Rajesh Narwal, David Fairman, Paul Robbins, Meina Liang, Amy Schneider, Carlos Chavez, Carina Herl, Min Pak, Hong Lu, Marlon Rebelatto, Keith Steele, Anmarie Boutrin, Li Shi, Shengyan Hong, Brandon Higgs, Lorin Roskos
  • Anti-B7-H1 antibodies for treating tumors
    Patent number: 10336823
    Abstract: Provided herein are methods of treating B7-H1-expressing tumors comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof.
    Type: Grant
    Filed: September 11, 2014
    Date of Patent: July 2, 2019
    Assignee: MedImmune Limited
    Inventors: Rajesh Narwal, David Fairman, Paul Robbins, Meina Liang, Amy Schneider, Carlos Chavez, Carina Herl, Min Pak, Hong Lu, Marlon Rebelatto, Keith Steele, Anmarie Boutrin, Li Shi, Shengyan Hong, Brandon Higgs, Lorin Roskos
  • ANTI-PCSK9-GLP-1 FUSIONS AND METHODS FOR USE
    Publication number: 20190092877
    Abstract: This application provides anti-PCSK9˜GLP-1 fusions and methods for use.
    Type: Application
    Filed: September 17, 2018
    Publication date: March 28, 2019
    Inventors: Anthony CELESTE, Matthieu CHODORGE, Andrew BUCHANAN, Cristina RONDINONE, Joseph GRIMSBY, Peter RAVN, Jonathan SEAMAN, David FAIRMAN
  • ANTI-PAR2 ANTIBODIES AND USES THEREOF
    Publication number: 20180305450
    Abstract: The present disclosure provides antibodies and antigen-binding fragments capable of binding PAR2. In some embodiments, the anti-PAR2 antibodies or antigen-binding fragments thereof bind PAR2 in a pH-dependent manner. The disclosure further provides methods for making and using the antibodies and antigen-binding fragments.
    Type: Application
    Filed: March 16, 2018
    Publication date: October 25, 2018
    Inventors: Claire Dobson, Richard Williams, Ian Gurrell, Sadhana Podichetty, David Fairman, Peter Thornton, Philip Newton
  • Anti-PCSK9-GLP-1 fusions and methods for use
    Patent number: 10077319
    Abstract: This application provides anti-PCSK9˜GLP-1 fusions and methods for use.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: September 18, 2018
    Assignees: MedImmune, LLC, MedImmune Limited
    Inventors: Anthony Celeste, Matthieu Chodorge, Andrew Buchanan, Cristina Rondinone, Joseph Grimsby, Peter Ravn, Jonathan Seaman, David Fairman
  • GLUCAGON/GLP-1 AGONISTS FOR THE TREATMENT OF OBESITY
    Publication number: 20170342121
    Abstract: This disclosure provides GLP-1/glue agon agonist peptides for the treatment of metabolic diseases, e.g., obesity.
    Type: Application
    Filed: August 10, 2017
    Publication date: November 30, 2017
    Inventors: Balaji Agoram, Madeleine Antonsson, Maria A. Bednarek, Nicole Burmeister, Lambertus Benthem, David Fairman, Maria Fritsch-Fredin, Ronald Jackson, Rasmus Jansson Lofmark, Jacqueline Metcalfe
  • Glucagon/GLP-1 agonists for the treatment of obesity
    Patent number: 9765130
    Abstract: This disclosure provides GLP-1/glue agon agonist peptides for the treatment of metabolic diseases, e.g., obesity.
    Type: Grant
    Filed: December 10, 2013
    Date of Patent: September 19, 2017
    Assignee: MEDIMMUNE LIMITED
    Inventors: Balaji Agoram, Madeleine Antonsson, Maria Bednarek, Nicole Burmeister, Lambertus Benthem, David Fairman, Maria Fritsch-Fredin, Ronald Jackson, Rasmus Jansson Lofmark, Jacqueline Metcalfe
  • ANTI-PCSK9-GLP-1 FUSIONS AND METHODS FOR USE
    Publication number: 20160369010
    Abstract: This application provides anti-PCSK9˜GLP-1 fusions and methods for use.
    Type: Application
    Filed: February 20, 2015
    Publication date: December 22, 2016
    Inventors: Anthony Celeste, Matthieu CHODORGE, Andrew BUCHANAN, Cristina RONDINONE, Joseph GRIMSBY, Peter RAVN, Jonathan SEAMAN, David FAIRMAN
  • Anti-B7-H1 Antibodies for Treating Tumors
    Publication number: 20160222120
    Abstract: Provided herein are methods of treating B7-H1-expressing tumors comprising administering an effective amount of MEDI4736 or an antigen-binding fragment thereof.
    Type: Application
    Filed: September 11, 2014
    Publication date: August 4, 2016
    Applicant: Medlmmune Limited
    Inventors: Rajesh Narwal, David Fairman, Paul Robbins, Meina Liang, Amy Schneider, Carlos Chavez, Carina Herl, Min Pak, Hong Lu, Marlon Rebelatto, Keith Steele, Anmarie Boutrin, Li Shi, Shengyan Hong, Brandon Higgs, Lorin Roskos